Singapore markets close in 3 hours 12 minutes

Trinity Capital Inc. (TRIN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.72-0.18 (-1.21%)
At close: 04:00PM EDT
14.88 +0.16 (+1.09%)
After hours: 05:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close14.90
Open14.94
Bid14.67 x 100
Ask14.75 x 100
Day's range14.60 - 14.94
52-week range12.22 - 15.44
Volume462,997
Avg. volume476,080
Market cap728.324M
Beta (5Y monthly)0.67
PE ratio (TTM)9.26
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.04 (13.86%)
Ex-dividend date27 Mar 2024
1y target estN/A
  • PR Newswire

    Trinity Capital Inc. Expands Operations into Europe

    Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced its strategic expansion into Europe with the appointment of London-based Craig Fox as Managing Director. This initiative aligns with the Company's long-term vision of supporting high-growth companies globally.

  • PR Newswire

    Metabolon Secures $60 Million Credit Facility to Drive Growth and Innovation

    Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announced that it has closed on a new $60 million credit facility. This significant investment, of which an initial $42.5 million was funded at closing, will be utilized to fuel the company's growth initiatives and expand its research and development efforts to further enhance its metabolomics platform.

  • PR Newswire

    Trinity Capital Inc. Provides $60 Million in Growth Capital to Metabolon

    Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $60 million in growth capital to Metabolon, a global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications.